Ardelyx (ARDX) vs CryoPort (CYRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CryoPort (CYRX) has outperformed Ardelyx (ARDX) over the past year, gaining 77.0% versus a loss of 36.9%. Over five years, ARDX leads with a +201.9% price change compared with -75.3% for CYRX. CryoPort is the larger company by market cap ($859.0 million vs $844.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARDX | CYRX |
|---|---|---|
| Share price | $3.27 | $16.96 |
| Market cap | $844.27M | $859.01M |
| 1-day change | +0.31% | -2.25% |
| YTD return | -44.08% | +80.73% |
| 1-year return | -36.94% | +77.04% |
| 5-year return | +201.85% | -75.31% |
| Forward P/E | 11.26 | — |
| EPS (TTM) | $-0.23 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $18.36 |
| 52-week low | $3.18 | $7.61 |
| Distance from 52-week high | -61.07% | -7.63% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +294.50% | +15.98% |
| Average volume | 4.10M | 632.63K |
| Shares outstanding | 258.19M | 50.65M |
| Employees | 489 | 684 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CYRX has outperformed ARDX by 114.0 percentage points over the past year.
About Ardelyx
ARDX stock →Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 489 employees
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
ARDX vs CYRX FAQ
Which is bigger, Ardelyx or CryoPort?
CryoPort (CYRX) is larger, with a market capitalization of $859.01M compared with $844.27M for Ardelyx (ARDX).
Which stock has performed better over the past year, ARDX or CYRX?
CYRX returned +77.04% over the past 12 months, compared with -36.94% for ARDX (price return, excluding dividends). Past performance does not predict future results.
Are Ardelyx and CryoPort in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.